Literature DB >> 16522456

CD8+ T lymphocytes and leukotriene B4: novel interactions in the persistence and progression of asthma.

Erwin W Gelfand1, Azzeddine Dakhama.   

Abstract

The contribution of CD8+ T cells to the development of airway hyperresponsiveness and airway inflammation has received increased attention recently. CD8+ T cells, which are capable of secreting TH2 cytokines, including IL-4, IL-5, and IL-13, have been described in asthmatic subjects and in animals sensitized and challenged with allergen. A subset of these IL-13-producing CD8+ T cells, effector memory CD8+ T cells in the mouse, express a high-affinity receptor for leukotriene B4 (BLT1), and expression of this receptor is essential for their accumulation in the lung and development of airway hyperresponsiveness and airway inflammation. A similar subset of CD8+/BLT1+/IL-13+ T cells has also been identified in the bronchoalveolar lavage fluid of asthmatic subjects, suggesting a pathogenic role for this unique subset of CD8+ T cells in asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522456     DOI: 10.1016/j.jaci.2005.12.1340

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  26 in total

1.  T-cell phenotypes are associated with serum IgE levels in Amish and Hutterite children.

Authors:  Cara L Hrusch; Michelle M Stein; Justyna Gozdz; Mark Holbreich; Erika von Mutius; Donata Vercelli; Carole Ober; Anne I Sperling
Journal:  J Allergy Clin Immunol       Date:  2019-08-08       Impact factor: 10.793

Review 2.  Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma.

Authors:  Erwin W Gelfand
Journal:  Semin Immunol       Date:  2017-10       Impact factor: 11.130

3.  Histamine-treated dendritic cells improve recruitment of type 2 CD8 T cells in the lungs of allergic mice.

Authors:  Maria M Amaral; Carolina Alvarez; Cecilia Langellotti; Jorge Geffner; Mónica Vermeulen
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

4.  Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.

Authors:  Grzegorz Woszczek; Li-Yuan Chen; Sara Alsaaty; Sahrudaya Nagineni; James H Shelhamer
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

5.  Leukotriene A4 Hydrolase Activation and Leukotriene B4 Production by Eosinophils in Severe Asthma.

Authors:  Kavita Pal; Xin Feng; John W Steinke; Marie D Burdick; Yun M Shim; Sun-Sang Sung; W Gerald Teague; Larry Borish
Journal:  Am J Respir Cell Mol Biol       Date:  2019-04       Impact factor: 6.914

6.  Leukotriene B4, administered via intracerebroventricular injection, attenuates the antigen-induced asthmatic response in sensitized guinea pigs.

Authors:  Yi-Liang Zhu; Shui-Jun Zhang; Yang-Mei Deng; Xin-Wei Dong; Jun-Xia Jiang; Qiang-Min Xie
Journal:  J Neuroinflammation       Date:  2010-02-11       Impact factor: 8.322

7.  Alteration of airway responsiveness mediated by receptors in ovalbumin-induced asthmatic E3 rats.

Authors:  Jing-Wen Long; Xu-Dong Yang; Lei Cao; She-Min Lu; Yong-Xiao Cao
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

Review 8.  Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.

Authors:  Eric Schauberger; Miriam Peinhaupt; Tareian Cazares; Andrew W Lindsley
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

9.  Steroidogenic enzyme Cyp11a1 regulates Type 2 CD8+ T cell skewing in allergic lung disease.

Authors:  Yi Jia; Joanne Domenico; Katsuyuki Takeda; Junyan Han; Meiqin Wang; Michael Armstrong; Nichole Reisdorph; Brian P O'Connor; Joseph J Lucas; Erwin W Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

Review 10.  The yin and yang of leukotriene B4 mediated inflammation in cancer.

Authors:  Venkatakrishna R Jala; Sobha R Bodduluri; Shuchismita R Satpathy; Zinal Chheda; Rajesh K Sharma; Bodduluri Haribabu
Journal:  Semin Immunol       Date:  2017-10-02       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.